TrialJournal of surgical oncology2017

Using the 21-gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trial.

Harry D Bear et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.